ANME aims at the European-wide recognition of CAM as a form of health protection for consumers and patients
A wide range of research approaches
Health research is much more than a question of efficacy, and as many CAM therapies are not single component based, this is more complex compared to the investigation of a single pharmaceutical
CAM and cancer discussed among MEP’s
Two groups of MEP’s are encouraging the European Commission and the European Parliament to support integration of CAM into the healthcare of EU citizens
CAM in Germany
Many German MDs are practising CAM, quite often they attend postgraduate courses related to CAM, and the citizens benefit from good reimbursement options.